Related Experiment Videos
Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy
Xian-Cheng Jiang1, Ira J Goldberg, Tae-Sik Park
1Department of Cell Biology, Downstate Medical Center, State University of New York, Brooklyn, New York, USA. xian-cheng.jiang@downstate.edu
Insights
This study explores the connection between sphingolipid metabolism and heart disease, including atherosclerosis and cardiomyopathy. It examines how lipid accumulation and inflammation contribute to vascular changes.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Molecular Biology
Background:
- Heart disease pathogenesis involves lipid accumulation and inflammation.
- Cholesterol accumulation and oxidation in arterial walls contribute to vascular thickening.
- Inflammatory reactions can be triggered by vessel wall injury, infections, or diseases like diabetes.
Purpose of the Study:
- To investigate the relationship between de novo sphingolipid synthesis and lipid metabolism.
- To explore the role of sphingolipids in the development of atherosclerosis.
- To examine the connection between sphingolipids and cardiomyopathy.
Main Methods:
- Literature review focusing on de novo sphingolipid synthesis.
- Analysis of lipid metabolism pathways in cardiovascular disease.
- Examination of molecular mechanisms linking sphingolipids to atherosclerosis and cardiomyopathy.
Main Results:
- Sphingolipid metabolism is intricately linked to overall lipid metabolism.
- Dysregulation of sphingolipids can promote atherosclerosis development.
- Alterations in sphingolipid pathways are associated with cardiomyopathy.
Conclusions:
- Sphingolipid metabolism represents a critical factor in cardiovascular health.
- Targeting sphingolipid pathways may offer novel therapeutic strategies for heart disease.
- Further research into sphingolipid biochemistry is warranted for understanding and treating atherosclerosis and cardiomyopathy.
Abstract:
Heart disease is widely believed to develop from two pathological processes. Circulating lipoproteins containing the nondegradable lipid, cholesterol, accumulate within the arterial wall and perhaps are oxidized to more toxic lipids. Both lipid accumulation and vascular reaction to the lipids lead to the gradual thickening of the vascular wall. A second major process that in some circumstances is a primary event is the development of a local inflammatory reaction. This might be a reaction to vessel wall injury that accompanies infections, immune disease, and perhaps diabetes and renal failure. In this chapter, we will focus on the relationship between de novo synthesis of sphingolipids and lipid metabolism, atherosclerosis, and cardiomyopathy.
Related Concept Videos
01:30Atherosclerosis I: Introduction
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:31Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
01:26Coronary Artery Disease II: Pathophysiology
01:26Atherosclerosis III: Management
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...